Pharma News, 2019

In the past, AstraZeneca's investors have hit out at the company for executive compensation they deemed over-the-top.

The face of HIV is aging.

(Reuters Health) - Kids with eczema - even mild eczema - may be more likely to have poor quality sleep than children who don’t have this common skin disorder, a UK study suggests.

MANILA/PARIS (Reuters) - The Philippine Department of Justice on Friday said it had found probable cause to indict officials from French drugmaker Sanofi and former and current Philippine heal...

WALTHAM, Mass.

GAITHERSBURG, Md.

A radical Parkinson's treatment that delivers a drug directly to the brain has been tested in people.

They say you need to get eight hours' sleep to prevent all kinds of diseases, from diabetes to dementia.

Horizon Pharma has announced positive Phase III clinical trial data for teprotumumab, as a treatment for active thyroid eye disease (TED).

New skin sensors are less invasive and don’t harm an infant’s fragile skin.

Janssen has announced the US Food and Drug Administration (FDA) approval of its novel drug Tremfya One-Press (guselkumab) for adults with moderate-to-severe plaque psoriasis.

NHS patients are set to receive therapy to “counteract the impact of harmful social media” as part of a new service designed to treat the rare eating disorder diabulimia.